CR10410A - Carboxamidas sustituidas. - Google Patents

Carboxamidas sustituidas.

Info

Publication number
CR10410A
CR10410A CR10410A CR10410A CR10410A CR 10410 A CR10410 A CR 10410A CR 10410 A CR10410 A CR 10410A CR 10410 A CR10410 A CR 10410A CR 10410 A CR10410 A CR 10410A
Authority
CR
Costa Rica
Prior art keywords
substituted
carboxamids
formula
pharmaceutically acceptable
pharmaceutical composition
Prior art date
Application number
CR10410A
Other languages
English (en)
Inventor
Thomas Backer Ryan
Joseph Fisher Matthew
Patrick Hollinshead Sean
Lee Kuklish Steven
C R Smith Edward
Takeuchi Kumiko
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CR10410A publication Critical patent/CR10410A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a un compuesto de carboxamida sustituida de formula I, o una sal del mismo farmaceuticamente aceptable, como se define en la presente, una composicion farmaceutica del mismo, y su uso en el tratamiento de dolor.
CR10410A 2006-06-08 2007-10-29 Carboxamidas sustituidas. CR10410A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81183906P 2006-06-08 2006-06-08

Publications (1)

Publication Number Publication Date
CR10410A true CR10410A (es) 2008-11-28

Family

ID=39673278

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10410A CR10410A (es) 2006-06-08 2007-10-29 Carboxamidas sustituidas.

Country Status (30)

Country Link
US (1) US7960419B2 (es)
EP (1) EP2076502B1 (es)
JP (1) JP5108878B2 (es)
KR (1) KR101051559B1 (es)
CN (1) CN101466691B (es)
AT (1) ATE509921T1 (es)
AU (1) AU2007347428B2 (es)
BR (1) BRPI0712862A2 (es)
CA (1) CA2652074C (es)
CR (1) CR10410A (es)
CY (1) CY1111588T1 (es)
DK (1) DK2076502T3 (es)
EA (1) EA014233B1 (es)
EC (1) ECSP088939A (es)
ES (1) ES2362949T3 (es)
HR (1) HRP20110436T1 (es)
IL (1) IL195632A (es)
MA (1) MA30620B1 (es)
MX (1) MX2008015485A (es)
MY (1) MY148084A (es)
NO (1) NO341474B1 (es)
NZ (1) NZ573352A (es)
PL (1) PL2076502T3 (es)
PT (1) PT2076502E (es)
RS (1) RS51818B (es)
SI (1) SI2076502T1 (es)
TN (1) TNSN08506A1 (es)
UA (1) UA95480C2 (es)
WO (1) WO2008103185A2 (es)
ZA (1) ZA200809111B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0804685D0 (en) 2008-03-13 2008-04-16 Univ Edinburgh Therapeutic compounds and their use
MX2010010781A (es) 2008-04-04 2010-12-14 Lilly Co Eli 3-indazolil-4-piridilisotiazoles.
WO2010146338A1 (en) * 2009-06-15 2010-12-23 The University Of Edinburgh Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders
KR101702159B1 (ko) 2009-09-16 2017-02-02 더 유니버시티 오브 에든버러 （４―페닐―피페리딘―1―일）―［５―（1ｈ―피라졸―４―일）―티오펜―３―일］―메탄온 화합물 및 그의 용도
JP5899202B2 (ja) 2010-04-29 2016-04-06 ザ ユニバーシティ オブ エディンバラ １１β−ＨＳＤ１の阻害剤としての３，３−二置換−（８−アザ−ビシクロ［３．２．１］オクタ−８−イル）−［５−（１Ｈ−ピラゾール−４−イル）−チオフェン−３−イル］−メタノン類
ES2641469T3 (es) 2012-11-13 2017-11-10 Nissan Chemical Industries, Ltd. Compuesto de 2-piridona
SG11201902588PA (en) 2016-09-23 2019-05-30 Bayer Ag N3-Cyclically Substituted Thienouracils And Use Thereof
CN117567266B (zh) * 2023-11-07 2024-06-14 康龙化成手性医药技术(宁波)有限公司 一种制备2-甲基环丙羧酸的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL72091A0 (en) * 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-aryl 5-isothiazolyl)urea derivatives
DE4328425A1 (de) 1993-08-24 1995-03-02 Basf Ag Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung
DK124393D0 (da) * 1993-11-03 1993-11-03 Lundbeck & Co As H Compounds
DE19542372A1 (de) * 1995-11-14 1997-05-15 Bayer Ag Acylierte 5-Aminoisothiazole
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
JP3411262B2 (ja) * 1999-08-20 2003-05-26 萬有製薬株式会社 新規スピロ化合物
CZ2004168A3 (cs) * 2001-08-06 2004-05-12 Pharmaciaáitaliaás@P@A Aminoizoxazolové derivátyŹ účinné jako kinázové inhibitoryŹ způsob jejich přípravy a farmaceutické prostředkyŹ které je obsahují
JP2007506741A (ja) * 2003-09-23 2007-03-22 メルク　エンド　カムパニー　インコーポレーテッド 向代謝性グルタミン酸受容体のピラゾール系調節剤
MXPA06013118A (es) * 2004-05-12 2007-02-28 Schering Corp Antagonistas de cxcr1 y cxcr2 de quimocina.
MX2007003377A (es) * 2004-09-23 2007-05-10 Pfizer Prod Inc Agonistas del receptor de trombopoyetina.

Also Published As

Publication number Publication date
MY148084A (en) 2013-02-28
UA95480C2 (uk) 2011-08-10
AU2007347428A1 (en) 2008-08-28
CN101466691B (zh) 2011-07-27
SI2076502T1 (sl) 2011-09-30
MX2008015485A (es) 2009-03-06
WO2008103185A3 (en) 2008-10-30
IL195632A0 (en) 2009-09-01
ZA200809111B (en) 2009-12-30
US20090182025A1 (en) 2009-07-16
CA2652074C (en) 2013-08-06
NO341474B1 (no) 2017-11-27
KR20090008460A (ko) 2009-01-21
EA014233B1 (ru) 2010-10-29
BRPI0712862A2 (pt) 2012-12-18
DK2076502T3 (da) 2011-07-25
TNSN08506A1 (en) 2010-04-14
CY1111588T1 (el) 2015-10-07
AU2007347428B2 (en) 2012-02-09
MA30620B1 (fr) 2009-08-03
NZ573352A (en) 2011-10-28
EP2076502A2 (en) 2009-07-08
ATE509921T1 (de) 2011-06-15
CA2652074A1 (en) 2008-08-28
PL2076502T3 (pl) 2011-09-30
ECSP088939A (es) 2009-01-30
JP2009539874A (ja) 2009-11-19
HRP20110436T1 (hr) 2011-08-31
EP2076502B1 (en) 2011-05-18
EA200870516A1 (ru) 2009-06-30
IL195632A (en) 2013-11-28
HK1131984A1 (en) 2010-02-12
WO2008103185A2 (en) 2008-08-28
RS51818B (sr) 2011-12-31
US7960419B2 (en) 2011-06-14
CN101466691A (zh) 2009-06-24
JP5108878B2 (ja) 2012-12-26
ES2362949T3 (es) 2011-07-15
KR101051559B1 (ko) 2011-07-22
NO20085028L (no) 2008-12-02
PT2076502E (pt) 2011-06-07

Similar Documents

Publication Publication Date Title
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
DE602008000754D1 (de) Tropanverbindungen
MY146662A (en) Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
CR10410A (es) Carboxamidas sustituidas.
TW200806299A (en) Treatment of pain
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
SE0401342D0 (sv) Therapeutic compounds
PT1973540E (pt) Utilização de derivados heterocíclicos benzo-fundidos de sulfamida para o tratamento de dor
MX2009005798A (es) Recuperacion de apoplejia.
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
DK1885187T3 (da) Fremgangsmåde til behandling af lægemiddelresistent cancer
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
EA201100502A1 (ru) Гликозидные производные и их применения
ATE474574T1 (de) Imidazoazephinonverbindungen
MX2008008470A (es) Nuevos derivados pirrolicos con actividad inhibidora de desacetilasa de histonas.
EA200870287A1 (ru) Амидные производные в качестве лигандов ионных каналов и фармацевтические композиции и способы их применения
EA200802000A1 (ru) Фармацевтически приемлемые соли и полиморфные формы
EA200970368A1 (ru) Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата
DOP2008000064A (es) Carboxamidas sustituidas.
UA103767C2 (ru) Карбоксамидные соединения для лечения метаболических расстройств
DE602005016711D1 (de) Isoxazolsäure-derivat zur linderung neuropathischer schmerzen